Enanta Pharmaceuticals | ENTA - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
AbbVie USD 444.6B 59.91B 2026-06
Amgen USD 195.44B 5.55B 2026-06
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Biogen USD 31.9B 5B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Heron Therapeutics USD 238M 7M 2025-12
Immunic USD 64M 23M 2025-12
Incyte USD 22.65B 3.92B 2026-06
Insmed USD 23.11B 12.19B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 599.1B 54.52B 2026-10
Karyopharm Therapeutics USD 126M 9M 2026-03
Ligand Pharmaceuticals USD 6.34B 2.35B 2026-06
Merck USD 317.37B 20.27B 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Novavax USD 1.09B 316M 2025-12
Pfizer USD 138.44B 15.37B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06